Glenn Grothman: “We discussed last week some of the issues that are of significance, and I don't think the press is paying enough…”

“We discussed last week some of the issues that are of significance, and I don't think the press is paying enough attention to them. We just had a little bit more progress toward the development of fenofibrate, which is a generic drug, which some researchers from Israel have had some success on in curing COVID. I want to talk about these successes and then talk what is going to be necessary to have happen to get this potentially lifesaving drug in the mainstream. Two researchers from Israel found 15 people who were on oxygen and had pneumonia; and of the 15 people, after giving them fenofibrate, a generic drug available for very little, they got out of the hospital in 5 days. The other took, I think, it was 14 days. That is pretty incredible stuff. If it could be used routinely, it would dramatically have reduced the number of deaths in this country. Right now there are a variety of people around the world trying to do research on this topic, including the University of Pennsylvania, and they are grateful they got some money from the U.S. Government. But given the promise of this drug, I think they should have gotten a lot more money to deal with it quickly. I have talked to the researchers, and they think they will be able to get together. I guess they need 700 patients before they can make a determination. They think they will be able to make a determination that this is a good drug by the end of March. That is not quick enough.…”